Mots-C Bulk

MOTS-c bulk procurement provides academic and private institutions with mass-quantities of pure, 16-amino-acid mitochondrial-derived peptide for high-throughput in vitro assays and longitudinal preclinical animal studies. PX1 Research delivers USA-manufactured, lot-verified MOTS-c featuring complete third-party RP-HPLC and Mass Spectrometry validation.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

MOTS-c bulk procurement provides academic and private institutions with mass-quantities of pure, 16-amino-acid mitochondrial-derived peptide for high-throughput in vitro assays and longitudinal preclinical animal studies. PX1 Research delivers USA-manufactured, lot-verified MOTS-c featuring complete third-party RP-HPLC and Mass Spectrometry validation.

Reviewed by PX1 Research scientific team

Key takeaways

  • [MOTS-c](/research-peptides/mots-c) bulk procurement refers to the acquisition of mass-scale, lyophilized mitochondrial-derived peptide (MOTS-c) tailored for high-throughput laboratory experimentation.
  • [MOTS-c](/research-peptides/mots-c) (Mitochondrial Open Reading Frame of the 12S rRNA Type-C) is a naturally occurring 16-amino-acid peptide encoded within the mitochondrial genome rather than the nuclear DNA.
  • The primary focus of ongoing preclinical literature regarding [MOTS-c](/research-peptides/mots-c) centers on metabolic regulation and glucose homeostasis.
  • Beyond baseline metabolic homeostasis, [MOTS-c](/research-peptides/mots-c) is widely studied for its role in exercise-capacity research and physical endurance adaptation.

Definition and Direct Procurement Context for Bulk MOTS-c

MOTS-c bulk procurement refers to the acquisition of mass-scale, lyophilized mitochondrial-derived peptide (MOTS-c) tailored for high-throughput laboratory experimentation. Sourcing MOTS-c in bulk quantities allows research teams to eliminate lot-to-lot variance, maintain consistent experimental parameters across extended murine models, and minimize per-milligram reagent costs for long-term project timelines.

When purchasing raw or vialed research compounds at scale, establishing stringent quality baselines is critical. Researchers require fully verified identity and purity parameters to ensure that observed cellular responses—such as changes in metabolic flux or cellular stress signaling—are directly attributable to the peptide sequence rather than trace synthesis impurities or bacterial endotoxins.

Genomic Origin and Structural Profile of MOTS-c

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-C) is a naturally occurring 16-amino-acid peptide encoded within the mitochondrial genome rather than the nuclear DNA. Identified as a key component of the mitochondrial-derived peptide family, MOTS-c acts as an endocrine-like signal that facilitates nuclear-mitochondrial communication during metabolic stress.

The primary sequence of MOTS-c—Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg—enables unique biological signaling. In response to cellular energy depletion or oxidative imbalance, MOTS-c translocates from the mitochondrion to the cell nucleus. Once localized in the nucleus, it binds to specific genomic regulatory regions, interacting with transcription factors such as NRF2 to orchestrate stress-response gene expression programs.

For investigators analyzing metabolic pathways, obtaining verified MOTS-c peptide samples ensures that structural fidelity is maintained, preserving the peptide's binding kinetics during in vitro receptor interaction studies.

Preclinical Research Landscape: Metabolic Regulation and AMPK Pathways

The primary focus of ongoing preclinical literature regarding MOTS-c centers on metabolic regulation and glucose homeostasis. Preclinical studies suggest that MOTS-c directly activates AMP-activated protein kinase (AMPK), a master regulator of cellular energy balance. Activation of the AMPK pathway promotes glucose uptake in skeletal muscle tissues independently of classic insulin signaling pathways.

In rodent models of diet-induced obesity and insulin resistance, administration of MOTS-c has demonstrated significant improvements in metabolic flexibility. In vitro assays using cultured myotubes reveal that treatment with MOTS-c increases GLUT4 translocation to the cell membrane, enhancing glucose uptake and stimulating fatty acid oxidation. These findings position the peptide as a critical reference tool for investigations into type 2 diabetes pathology and metabolic syndrome models.

Data compiled across the PX1 Research hub indicate that researchers evaluating systemic energy balance frequently measure MOTS-c concentrations alongside circulating lipid profiles, mitochondrial respiration rates, and tissue-specific glycogen accumulation.

Exercise-Capacity and Physical Performance Research in Animal Models

Beyond baseline metabolic homeostasis, MOTS-c is widely studied for its role in exercise-capacity research and physical endurance adaptation. Animal studies show that endogenous levels of MOTS-c rise significantly in response to acute physical exertion, suggesting an adaptive role in cellular strain management.

In sedentary and aging rodent cohorts, exogenous supplementation of MOTS-c has been reported to enhance treadmill running capacity, increase maximal oxygen consumption (VO2 peak), and improve heat shock protein responses within skeletal muscle tissue. Researchers hypothesize that MOTS-c modulates skeletal muscle plasticity by promoting mitochondrial biogenesis and regulating amino acid metabolism during high-energy demand scenarios.

Because large-scale animal performance studies require sustained dosing regimens across control and experimental cohorts, obtaining stable bulk research peptides is essential for maintaining uniform administration schedules without introducing batch-dependent activity fluctuations.

Comparative Analysis: MOTS-c, SS-31, and Humanin in Mitochondrial Biology

In the domain of mitochondrial bioenergetics research, MOTS-c is frequently evaluated alongside other mitochondrial-active compounds. MOTS-c represents a distinct regulatory signaling axis within the mitochondrial-derived peptide class, whereas compounds such as Humanin focus heavily on cytoprotection and apoptosis inhibition under ischemic or neurotoxic conditions. In contrast, synthetic cell-permeable peptides like SS-31 (Elamipretide) interact directly with inner mitochondrial membrane lipids—specifically cardiolipin—to stabilize cristae structure and reduce electron leakage without operating through nuclear transcription pathways. Researchers seeking to compare retrograde nuclear signaling against membrane-stabilizing mechanisms often source these distinct analogs concurrently from the comprehensive PX1 peptide catalog.

Quality Verification Metrics for Bulk MOTS-c Procurement

When procuring bulk quantities of synthetic peptides for formal research, rigorous quality control measures are non-negotiable. Substandard synthesis can lead to residual solvents, truncated peptide sequences, counter-ion imbalance, or high endotoxin burdens that invalidate experimental data.

PX1 Research enforces stringent analytical standards for all bulk peptide lots. Every batch undergoes comprehensive testing in an ISO 17025 accredited analytical facility using two primary methodologies:

1. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC): Ensures purity levels equal to or exceeding 98%. RP-HPLC isolates the primary MOTS-c sequence from synthesis side-products, guaranteeing single-peak clarity.

2. Electrospray Ionization Mass Spectrometry (ESI-MS): Confirms exact molecular mass (theoretical MW: 2174.6 g/mol) to verify sequence integrity and eliminate the possibility of amino acid substitution errors.

Additionally, bulk lots undergo quantitative Limulus Amebocyte Lysate (LAL) testing to verify low endotoxin limits (<0.01 EU/mg). This step is critical for cellular culture assays and in vivo injections, as bacterial endotoxins provoke acute inflammatory responses that corrupt biological datasets.

Laboratory Reconstitution, Storage, and Handling Guidelines

To maintain chemical stability and functional viability, lyophilized bulk MOTS-c must be handled according to strict physical chemistry protocols upon arrival at the research facility.

Lyophilized MOTS-c powder should be stored long-term at -20°C or -80°C in a desiccated environment. Before opening the vial, allow the container to equilibrate to room temperature to prevent condensation from introducing moisture into the cake, which can accelerate peptide degradation.

For reconstitution, use sterile, deaerated buffers such as Bacteriostatic Water for Injection or sterile Phosphate-Buffered Saline (PBS, pH 7.4). For assays sensitive to benzyl alcohol, sterile 0.9% Sodium Chloride is recommended. Swirl the vial gently to dissolve the powder; avoid aggressive vortexing, which can induce mechanical shear stress and peptide aggregation.

Once reconstituted, working aliquots should be frozen immediately at -80°C. Repeated freeze-thaw cycles must be strictly avoided, as phase changes degrade the primary structure and alter solution concentration.

Institutional Sourcing and Supply Chain Reliability with PX1 Research

Managing ongoing preclinical studies requires a transparent, dependable supply chain. PX1 Research manufactures research compounds under strict quality management systems in USA-based facilities, providing continuous inventory availability for academic laboratories, biotechnology enterprises, and contract research organizations (CROs).

Bulk orders are processed with same-day shipping from dual logistics hubs located in California and Arizona. Every bulk shipment includes lot-traceable documentation, physical Certificates of Analysis (COA), and complete raw chromatography spectral data. Through our wholesale procurement portal, institutional buyers can establish customized delivery schedules, secure dedicated batch reservations, and access tiered volume pricing for longitudinal trial requirements.

Frequently Asked Questions

What is the theoretical molecular weight of MOTS-c for analytical verification?

The theoretical molecular weight of MOTS-c (C101H152N28O22S2) is approximately 2174.6 g/mol. Mass spectrometry testing provided on PX1 Research COAs verifies this exact mass figure.

Why is endotoxin testing critical when purchasing MOTS-c in bulk?

Bacterial endotoxins (lipopolysaccharides) provoke immune reactions in cultured cells and animal models. Low endotoxin limits (<0.01 EU/mg) ensure that experimental outcomes reflect the biological activity of MOTS-c rather than immune system responses to contaminants.

How should reconstituted MOTS-c solutions be stored for long-term study protocols?

Reconstituted MOTS-c should be divided into single-use experimental aliquots and stored at -80°C. Avoid repeated freeze-thaw cycles, which cause physical aggregation and structural degradation of the peptide.

What is the recommended solvent for reconstituting bulk MOTS-c powder?

Reconstitution is typically performed using sterile Bacteriostatic Water or sterile Phosphate-Buffered Saline (PBS, pH 7.4), depending on whether the downstream assay requires a preservative-free buffer.

Does PX1 Research provide lot-specific COAs for bulk peptide purchases?

Yes. Every bulk shipment of MOTS-c includes a lot-specific Certificate of Analysis generated by an independent ISO 17025 accredited laboratory, featuring raw RP-HPLC and Mass Spectrometry spectra.

How does MOTS-c differ mechanism-wise from synthetic compounds like SS-31?

MOTS-c is a nuclear-mitochondrial signaling peptide that translocates to the nucleus to regulate gene expression and AMPK pathways. SS-31 directly targets cardiolipin on the inner mitochondrial membrane to optimize electron transport chain mechanics without acting as a genomic signaling factor.

Can institutions request dedicated batch reservations for longitudinal animal studies?

Yes. Through the PX1 Research wholesale program, research facilities can reserve specific manufacturing lots to guarantee lot consistency across multi-year experimental timelines.

Where are PX1 Research bulk peptides manufactured and shipped from?

All PX1 Research compounds are manufactured in USA-based facilities and dispatched same-day (Monday through Friday) from logistics centers located in California and Arizona.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.